Anastomotic Leakage After Colorectal Surgery.
Condition(s) studied
Investigational drug(s) / intervention(s)
Patients Undergoing Colorectal Resection with Anastomosis: All eligible patients undergoing elective/emergency colorectal surgery with primary anastomosis (e.g., ileocolic, colocolic, colorectal, or coloanal)
Study summary
Anastomotic leakage (AL) is a severe complication after colorectal surgery, with incidence rates of 2-30%. This prospective, single-center observational cohort study aims to identify and quantify independent risk factors for AL, determine its incidence and impact on outcomes, and develop a predictive model. Approximately 430 patients undergoing colorectal resection with anastomosis will be enrolled from August 2025 to August 2026. Risk factors will be assessed preoperatively, intraoperatively, and postoperatively. AL will be defined and graded per the International Study Group of Rectal Cancer (ISGRC) criteria.
Eligibility
Primary outcome measure(s)
- Incidence of Anastomotic Leakage (AL) — Within 30 days post-surgery.
Proportion of patients developing AL within 30 days post-surgery or during hospital stay (whichever longer), diagnosed clinically, radiologically, or operatively per ISGRC definition
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Minia University Hospital | Minya | Minya Governorate | Recruiting |
More Minia University trials in Egypt
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07144683 on ClinicalTrials.gov ↗ ← All trials in Egypt